Differences in the Production of And/or the Response to Interleukin-2 by T Lymphocytes from Patients with the Various Connective Tissue Diseases

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 1984 Jan 1

PMID 6609414

Citations 9

Authors

J Alcocer-Varela

A Laffon

D Alarcon-Segovia

Affiliations

Soon will be listed here.

Abstract

We have studied the production of and the response to interleukin-2 (IL-2) by blood T lymphocytes from 83 untreated patients with six connective tissue diseases, each patient with a healthy age/sex matched control. SLE patients had markedly decreased production of IL-2, both when elicited with phytohemagglutinin (PHA) and when promoted by autologous mixed lymphocyte reaction (AMLR). They also had decreased response to IL-2. Conversely, patients with scleroderma had normal production of IL-2 with both stimuli and their lymphocytes responded to IL-2 similarly to, or even better than, controls. Patients with mixed connective tissue disease had decreased production of IL-2 upon PHA stimulation but it was normal in AMLR systems. Response to IL-2 was moderately diminished. Patients with rheumatoid arthritis showed moderately decreased production of Il-2 with both stimuli but a normal response to Il-2. Patients with Sjögren's syndrome had similar, but less marked defects than those of SLE. Patients with dermato-polymyositis showed decreased production of IL-2 in AMLR but normal production of IL-2 in response to PHA as well as normal response to IL-2. The differences found between the various connective tissue diseases support the notion that the T cell dysregulation that results from or leads to "autoimmunity" in them is peculiar to each disease.

Citing Articles

Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome.

Iizuka-Koga M, Asashima H, Ando M, Lai C, Mochizuki S, Nakanishi M Stem Cell Reports. 2017; 8(5):1155-1163.

PMID: 28494936 PMC: 5425788. DOI: 10.1016/j.stemcr.2017.04.010.

Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

Carpintero M, Martinez L, Fernandez I, Romero A, Mejia C, Zang Y Lupus. 2015; 24(10):1057-66.

PMID: 25736140 PMC: 4529793. DOI: 10.1177/0961203315575586.

Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2.

Gonzalez-Amaro R, Alcocer-Varela J, Martinez-Cordero E, Alarcon-Segovia D J Clin Immunol. 1984; 4(4):273-9.

PMID: 6611347 DOI: 10.1007/BF00915294.

Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases.

Laffon A, Alcocer-Varela J, Alarcon-Segovia D Rheumatol Int. 1983; 3(3):117-28.

PMID: 6230705 DOI: 10.1007/BF00541191.

Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.

Cross S, Hazelton R Ann Rheum Dis. 1985; 44(4):224-31.

PMID: 3157353 PMC: 1001617. DOI: 10.1136/ard.44.4.224.

References

Gilman S, Rosenberg J, FELDMAN J . T lymphocytes of young and aged rats. II. Functional defects and the role of interleukin-2. J Immunol. 1982; 128(2):644-50. View

Gillis S, Ferm M, Ou W, Smith K . T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978; 120(6):2027-32. View

Crabtree G, Gillis S, Smith K, Munck A . Glucocorticoids and immune responses. Arthritis Rheum. 1979; 22(11):1246-56. DOI: 10.1002/art.1780221112. View

Inoshita T, Whiteside T, Rodnan G, Taylor F . Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma). J Lab Clin Med. 1981; 97(2):264-77. View

Alarcon-Segovia D, Hernandez-Ortiz J . Articular manifestations of mixed connective tissue disease. Arthritis Rheum. 1979; 22(1):43-51. DOI: 10.1002/art.1780220107. View

Bohan A, Peter J . Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975; 292(7):344-7. DOI: 10.1056/NEJM197502132920706. View

Tomonari K, Wakisaka A, Aizawa M . Self recognition by autologous mixed lymphocyte reaction-primed cells. J Immunol. 1980; 125(4):1596-600. View

ROPES M, BENNETT G, COBB S, JACOX R, JESSAR R . 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958; 9(4):175-6. View

Alarcon-Segovia D, Ruiz-Arguelles A . Suppressor cell loss and dysfunction in mixed connective tissue disease. Arthritis Rheum. 1980; 23(3):314-8. DOI: 10.1002/art.1780230308. View

10.

Laffon A, Alcocer-Varela J, Alarcon-Segovia D . Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases. Rheumatol Int. 1983; 3(3):117-28. DOI: 10.1007/BF00541191. View

11.

Gillis S, Kozak R, Durante M, Weksler M . Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest. 1981; 67(4):937-42. PMC: 370650. DOI: 10.1172/jci110143. View

12.

Bresnihan B, Jasin H . Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977; 59(1):106-16. PMC: 333337. DOI: 10.1172/JCI108607. View

13.

Palacios R, Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A, Diaz-Jouanen E . Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor. J Clin Lab Immunol. 1981; 5(2):71-80. View

14.

Palacios R, Ruiz-Arguelles A, Alarcon-Segovia D . Human post-thymic precursor cells in health and disease. IX. Immunoregulatory T cell circuits in peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol. 1981; 43(3):473-7. PMC: 1537178. View

15.

Kramer M, Koszinowski U . T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function. J Immunol. 1982; 128(2):784-90. View

16.

Heijnen C, Pot K, Kater L, Kluin-Nelemans H, Uytdehaag F, Ballieux R . Functional analysis of the defective T cell regulation of the antigen-specific PFC response in SLE patients: differentiation of suppressor precursor cells to suppressor effector cells. Clin Exp Immunol. 1982; 47(2):359-67. PMC: 1536531. View

17.

. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980; 23(5):581-90. DOI: 10.1002/art.1780230510. View

18.

Wofsy D, MURPHY E, Roths J, Dauphinee M, Kipper S, Talal N . Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med. 1981; 154(5):1671-80. PMC: 2186500. DOI: 10.1084/jem.154.5.1671. View

19.

Palacios R, Llorente L, Alarcon-Segovia D, Ruiz-Arguelles A, Diaz-Jouanen E . Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction. J Clin Invest. 1980; 65(6):1527-30. PMC: 371493. DOI: 10.1172/JCI109819. View

20.

Hamilton M, Winfield J . Tgamma cells in systemic lupus erythematosus. Variation with disease activity. Arthritis Rheum. 1979; 22(1):1-6. DOI: 10.1002/art.1780220101. View